Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.

Wu, Jashin J; Rowan, Christopher G; Bebchuk, Judith D; Anthony, Mary S

Wu, Jashin J; Rowan, Christopher G; Bebchuk, Judith D; Anthony, Mary S.

Affiliation

Wu JJ; Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA. jashinwu@hotmail.com.
Rowan CG; American Medical Group Association, Alexandria, VA, USA.
Bebchuk JD; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Anthony MS; RTI Health Solutions, Durham, NC, USA.

Int J Dermatol ; 54(10): e442-5, 2015 Oct.

Article in En | MEDLINE | ID: mdl-26234307

Subject(s)

Arthritis, Psoriatic/blood; Arthritis, Psoriatic/drug therapy; Arthritis, Rheumatoid/blood; Arthritis, Rheumatoid/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Cholesterol/blood; Drug Therapy, Combination; Humans; Immunosuppressive Agents/therapeutic use; Lipoproteins, HDL/blood; Lipoproteins, LDL/blood; Methotrexate/therapeutic use; Psoriasis/blood; Psoriasis/drug therapy; Retrospective Studies; Triglycerides/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Arthritis, Psoriatic / Tumor Necrosis Factor-alpha Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Dermatol Year: 2015 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google